Congratulations to the winners of our Top 10 Abstracts for the e-EULAR congress 2020

 

Wednesday 3rd June 2020:

  • OP0092 "Optimizing a Definition of Lupus Low Disease Activity State (LDA) for Daily Clinical Practice: SLE-DAS LDA vs LLDAS" by H. Assunção et al.

 

Thursday 4th June 2020:

  • OP0131 "Gut Derived Acetate Promotes Regulatory B-Cells with Anti-Inflammatory Effects" by C. Daien et al.

  • OP0176 "Chronological Order of Decrease of Synovitis, Osteitis and Tenosynovitis in Arthritis Patients Receiving First DMARD-Treatment" by X. Matthijssen et al.

  • OP0109 "Co-Medication with a Conventional Synthetic DMARD in Patients with Axial Spondyloarthritis is Associated with Improved Retention of TNF Inhibitors: Results from the EUROSPA Collaboration" by M. Nissen et al.

  • THU0096 "Revisiting the Remission Criteria for Rheumatoid Arthritis by Excluding Patient Global Assessment: An Individual Patient Meta-Analysis Including 5792 Patients" by R. J. O. Ferreira et al.

  • THU0214 "Long-Term Effectiveness of Methotrexate with Step Down Glucocorticoid Bridging (Cobra Slim) Versus Other Conventional DMARD Regimens as Initial RA Therapy: 5-Year Outcomes of the CARERA Trial" by V. Stouten et al.

 

Friday 5th June 2020:

  • OP0294 "Differemtial Influence of Co-Morbidities on Site of Fragility Fractures" by M. Dey et al.

 

Saturday 6th June 2020:

  • SAT0366 "Clinical Response to Biologic DMARDs in Axial Spondyloarthritis and Axial Psoriatic Arthritis. Different Diseases, Same Outcomes?" by D. Benavent et al.
  •  
  • OP0198 "A Systematic Review to Inform the EULAR Points to Consider When Analysing and Reporting Comparative Effectiveness Research with Observational Data in Rheumatology" by K. Lauper et al.